Targeting intracellular oncoproteins with antibody therapy or vaccination.
about
Survivin: a unique target for tumor therapySpecificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerIDO2: A Pathogenic Mediator of Inflammatory AutoimmunityIBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CAInvestigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes.Intravital and whole-organ imaging reveals capture of melanoma-derived antigen by lymph node subcapsular macrophages leading to widespread deposition on follicular dendritic cells.IgE-based immunotherapy of cancer: challenges and chances.Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.Phosphatase of regenerating liver: a novel target for cancer therapy.Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy.Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.Hidden immunotherapy targets challenge dogmaThe pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaTargeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.PRL3-zumab, a first-in-class humanized antibody for cancer therapy.Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsBroad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.Antibody-based immunotherapy of cancer.Electro-gene-transfer as a new tool for cancer immunotherapy in animals.Preclinical vaccines against mammary carcinoma.Monoclonal antibodies as therapeutics in human malignancies.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases.High folic acid diet enhances tumour growth in PyMT-induced breast cancer.Therapeutic Antibodies against Intracellular Tumor AntigensSuppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway.Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy.Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.
P2860
Q26747332-9EB36331-709C-4F62-836A-182E6ED098A8Q26853171-CB01B7F7-8B8B-424D-BB76-BE451D0FE6ECQ28069295-BD484C1F-083B-472C-BC49-F7D71D81C8E6Q28660580-54070C3D-53B4-4BFC-A4D2-5D5AD3641FCBQ30457615-9296D28B-3E15-4692-8CE9-6F623C38E1A0Q30558949-E1E8C8E5-CF12-4211-BC96-0A754ECB506CQ30627418-F5E07DAD-0509-473E-A56C-3815A85E61A8Q33619979-5A8716EE-1FD8-4417-A84D-492D5EFBB502Q34128485-67E30754-1EB9-4ADD-AC93-CF4DA2DD7906Q34437541-CDFDF568-AA15-442B-8B13-2ED40CC4D0D3Q35626579-6F4C6063-72E9-4EFA-8BBE-E0DBB7518153Q35889827-994CB5C3-F6BF-4A34-8627-9F5A92FA8CA1Q36184951-D90BA801-57F2-4D22-A51D-7A38BDEBF61FQ36510458-ED1C85A5-9147-4AD5-9B70-D400B7754B53Q36864003-1444E8D5-6AF1-4A06-803E-11B04BE7D3ECQ37236903-C6080FE8-F440-44C8-A344-534689D15DE0Q37277211-587EFDC7-8B70-43F8-BB70-EE3886CC873DQ37352107-836943E8-0717-4449-9767-6DF96292A517Q37381632-0DC77428-DFDE-46D5-B382-21B30B9BB2CBQ37659113-C5C13AAD-391C-4C22-B77B-D8D89FCDFB17Q37994278-FD2CCA3C-4BDC-48C3-ADA6-474DAE3A865BQ38055259-E59F887D-86CB-43AA-A426-300BFA6071F4Q38160252-B6DF5684-99CA-4BC8-B044-C8FA91DED357Q38206275-6B0971E3-15FB-4A39-9620-1B2542646BC2Q38644355-9920BF4D-9300-4063-B9B2-646978B1B2C2Q39646994-D0F78E10-582D-4C97-8500-48421F9B623CQ40353665-80E5639F-F114-4D37-B97F-272C2B6FF6E7Q41462883-2F32C661-1944-467C-AEF6-450AD7B8B704Q43522873-95B8D2DA-367B-45A6-BDAB-213E220E5858Q47105994-DD8538C3-DC82-45EA-A8BD-C7C5419A783EQ47335259-066B59C8-981A-40E4-9350-6778E292077EQ48103763-8B30D8BB-EA73-4E36-85A0-F70FE073D777Q48825054-EC46284E-840A-4FEB-BCA5-F560E5A1F755
P2860
Targeting intracellular oncoproteins with antibody therapy or vaccination.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@en
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@nl
type
label
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@en
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@nl
prefLabel
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@en
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@nl
P2093
P2860
P1476
Targeting intracellular oncoproteins with antibody therapy or vaccination.
@en
P2093
Abdul Qader O Al-Aidaroos
Caixia Huang
Cheng Peow Bobby Tan
Cheng William Hong
Jing Ping Tang
Leyon Varghese
P2860
P304
P356
10.1126/SCITRANSLMED.3002296
P407
P577
2011-09-01T00:00:00Z